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Bones and soft tissues of hands and feet can be affected by
different conditions, including genetic, metabolic or sys-
temic disorders [1]. Acromegaly is a condition caused by
excessive secretion of growth hormone (GH) leading to
elevated insulin growth factor-1 (IGF-1) levels, which is
characterised by somatic overgrowth and physical dis-
figurement notably affecting hands and feet [2]. However,
there are other conditions that can mimick the clinical fea-
tures seen in acromegaly without GH/IGF-1 anomalies,
termed as pseudoacromegaly [1].
A 3-year-old boy was noted to have large hands and feet,
severe joint pain and hyperhidrosis. Later he developed
forehead skin furrowing (pachydermia), but was not diag-
nosed until the age of 26, when he was referred to an
endocrinologist with the suspicion of acrogigantism. IGF-1
level was not elevated, random GH 0.14 µg/l, GH after
glucose-load was 0.46 µg/l. He has pachydermoperiostosis
due to a homozygous HPGD (15-hydroxyprostaglandin-
dehydrogenase) mutation (c.175-176delCT). His hands and
feet are remarkably large and fleshy with long and thick-
ened fingers and toes, prominent digital clubbing and loss of
the normal contour of the widened wrists and ankles (Fig. 1,
left subject). Similar acral features can be seen in acrome-
galy (Fig. 1, middle subject), while both are remarkably
different from a healthy male (Fig. 1, right subject). The left
patient had other clinical features characteristic of pachy-
dermoperiostosis, including seborrhoea, long eyelashes,
blepharoptosis, peri-articular oedemas, synovial effusions
and periodic watery diarrhoea. Although tall stature is not a
classical feature of pachydermoperiostosis [3], this patient’s
height (200 cm, midparental-height 181 cm) adds further
diagnostic challenges to distinguish from young-onset
acromegaly. His brother presented at the age of 3 with
arthralgia and bone and skin manifestations; he carries
the same homozygous mutation, while parents are
heterozygous.
Pachydermoperiostosis (primary autosomal recessive
hypertrophic osteoarthropathy) is a rare condition char-
acterised by digital clubbing, joint problems and pachy-
dermia, but other skin manifestations due to dermal and
sebaceous gland hypertrophy can be found [1]. HPGD loss
leads to accumulation of circulating prostaglandins, sug-
gested to play a role in the development of the character-
istic signs and symptoms [3]. Pachydermoperiostosis-
related acral abnormalities may overlap with those seen in
acromegaly, including broadened extremities, widened,
thickened and stubby fingers, and thickened soft tissue. In
acromegaly, excessive GH/IGF-1 leads to periosteal bone
formation, growth of synovial tissue, cartilage and leading
to hypertrophic arthropathy associated with pain and
deformity [2], as also seen in pachydermoperiostosis.
Cutis verticis gyrate, facial coarsening, hyperhidrosis,
seborrhoea and acne are common in pachydermoper-
iostosis as well as in acromegaly. However, other mani-
festations characteristic in pachydermoperiostosis, but not
seen in acromegaly, are blepharoptosis, long eyelashes,
myelofibrosis, hypoalbuminemia, peptic ulcer, gastric
cancer or watery diarrhoea in response to certain triggers,
such as cold drinks, greasy food or sexual activity [1].
Pachydermoperiostosis diagnosis is often established by
geneticists or rheumatologists; however, these patients
may be first referred for investigation of possible GH
excess to an endocrinologist, as in our case and in several
cases reported in the literature, thus we should be aware of
pachydermoperiostosis as a pseudoacromegaly condition
and aid in establishing its diagnosis [1].
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Fig. 1 Hands, feet and facial
appearance of a tall patient with
pachydermoperiostosis (left
subject), in comparison with a
patient with acromegaly (middle
subject) and a healthy male
(right subject). Note the digital
clubbing and the loss of contour
of the wrist and ankle in the
patient with
pachydermoperiostosis
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